BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

538837

JSTL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Jeevan Scientific Technology L Share Price Update

As of the latest trading session, Jeevan Scientific Technology L share price is currently at ₹ 41.78, which is down by ₹ -1.07 from its previous closing. Today, the stock has fluctuated between ₹ 41.78 and ₹ 44.65. Over the past year, Jeevan Scientific Technology L has achieved a return of -20.41 %. In the last month alone, the return has been 2.98 %. Read More...

Jeevan Scientific Technology L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    64.67

  • P/E Ratio (TTM)

    49.74

  • Beta

    0.56

  • Book Value / share

    32.36

  • Return on equity

    -2.16%

  • EPS (TTM)

    0.84

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.32

info icon alternate text

Jeevan Scientific Technology L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 11.87
Operating Expense 11.32
Net Profit 0.32
Net Profit Margin (%) 2.69
Earnings Per Share (EPS) 0.21
EBITDA 2.26
Effective Tax Rate (%) 57.14
Particulars SEP 2024 (Values in Cr)
Revenue 10.30
Operating Expense 9.87
Net Profit 0.15
Net Profit Margin (%) 1.45
Earnings Per Share (EPS) 0.10
EBITDA 2.11
Effective Tax Rate (%) 74.57
Particulars JUN 2024 (Values in Cr)
Revenue 12.52
Operating Expense 10.55
Net Profit 1.60
Net Profit Margin (%) 12.77
Earnings Per Share (EPS) 1.03
EBITDA 3.50
Effective Tax Rate (%) 22.70
Particulars MAR 2024 (Values in Cr)
Revenue 9.92
Operating Expense 10.94
Net Profit -0.74
Net Profit Margin (%) -7.45
Earnings Per Share (EPS) -0.48
EBITDA 0.80
Effective Tax Rate (%) 3.94
Particulars DEC 2023 (Values in Cr)
Revenue 10.13
Operating Expense 10.51
Net Profit -0.39
Net Profit Margin (%) -3.84
Earnings Per Share (EPS) -0.25
EBITDA 0.98
Effective Tax Rate (%) 22.00
Particulars MAR 2024 (Values in Cr)
Revenue 38.50
Operating Expense 40.41
Net Profit -1.05
Net Profit Margin (%) -2.72
Earnings Per Share (EPS) -0.68
EBITDA 5.05
Effective Tax Rate (%) 14.63
Particulars MAR 2023 (Values in Cr)
Revenue 36.18
Operating Expense 40.86
Net Profit -3.00
Net Profit Margin (%) -8.29
Earnings Per Share (EPS) -1.96
EBITDA 2.34
Effective Tax Rate (%) 17.12
Particulars MAR 2022 (Values in Cr)
Revenue 56.55
Operating Expense 44.12
Net Profit 12.26
Net Profit Margin (%) 21.67
Earnings Per Share (EPS) 8.15
EBITDA 22.99
Effective Tax Rate (%) 33.18
Particulars MAR 2021 (Values in Cr)
Revenue 41.39
Operating Expense 29.66
Net Profit 11.26
Net Profit Margin (%) 27.20
Earnings Per Share (EPS) 7.40
EBITDA 18.86
Effective Tax Rate (%) 14.56
Particulars MAR 2020 (Values in Cr)
Revenue 20.57
Operating Expense 25.47
Net Profit -7.81
Net Profit Margin (%) -37.96
Earnings Per Share (EPS) -5.12
EBITDA -3.59
Effective Tax Rate (%) 20.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.28
ROE % -2.75
ROCE % -1.04
Total Debt to Total Equity 0.24
EBITDA Margin 13.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.13
ROE % -6.20
ROCE % -4.33
Total Debt to Total Equity 0.23
EBITDA Margin 6.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 21.66
ROCE % 27.40
Total Debt to Total Equity 0.27
EBITDA Margin 27.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.89
ROE % 40.32
ROCE % 36.52
Total Debt to Total Equity 0.49
EBITDA Margin 42.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.18
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.66
EBITDA Margin -14.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.53
ROE % -2.16
ROCE % -0.85
Total Debt to Total Equity 0.15
EBITDA Margin 13.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.21
ROE % -6.07
ROCE % -4.32
Total Debt to Total Equity 0.22
EBITDA Margin 6.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 22.02
ROCE % 27.70
Total Debt to Total Equity 0.26
EBITDA Margin 33.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.69
ROE % 36.81
ROCE % 33.44
Total Debt to Total Equity 0.46
EBITDA Margin 46.97
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.63
EBITDA Margin -15.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.54
Total Assets 67.86
Total Liabilities 67.86
Total Equity 48.63
Share Outstanding 15480215
Price to Book Ratio 1.63
Return on Assets (%) -1.91
Return on Capital (%) -2.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.83
Total Assets 65.92
Total Liabilities 65.92
Total Equity 48.42
Share Outstanding 15480215
Price to Book Ratio 1.56
Return on Assets (%) -4.62
Return on Capital (%) -5.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 15301465
Price to Book Ratio 3.93
Return on Assets (%) 15.33
Return on Capital (%) 18.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.21
Total Assets 65.97
Total Liabilities 65.97
Total Equity 35.02
Share Outstanding 15301465
Price to Book Ratio 2.59
Return on Assets (%) 17.79
Return on Capital (%) 25.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.19
Total Assets 53.87
Total Liabilities 53.87
Total Equity 23.22
Share Outstanding 15301465
Price to Book Ratio 0.99
Return on Assets (%) -15.93
Return on Capital (%) -22.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 59.91
Total Liabilities 59.91
Total Equity 48.80
Share Outstanding 15480215
Price to Book Ratio 1.63
Return on Assets (%) -1.75
Return on Capital (%) -1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.12
Total Assets 63.75
Total Liabilities 63.75
Total Equity 48.31
Share Outstanding 15480215
Price to Book Ratio 1.56
Return on Assets (%) -4.71
Return on Capital (%) -5.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 15301465
Price to Book Ratio 3.93
Return on Assets (%) 15.74
Return on Capital (%) 19.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 63.77
Total Liabilities 63.77
Total Equity 36.24
Share Outstanding 15301465
Price to Book Ratio 2.59
Return on Assets (%) 17.65
Return on Capital (%) 24.16
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.88
Total Assets 52.87
Total Liabilities 52.87
Total Equity 24.92
Share Outstanding 15301465
Price to Book Ratio 0.99
Return on Assets (%) -14.77
Return on Capital (%) -19.44
Particulars MAR 2024 (Values in Cr)
Net Income -1.60
Cash from Operations 4.66
Cash from Investing -11.52
Cash from Financing 2.34
Net change in Cash -6.28
Free Cash Flow 16.69
Particulars MAR 2023 (Values in Cr)
Net Income -3.68
Cash from Operations -3.65
Cash from Investing -6.93
Cash from Financing -9.54
Net change in Cash -22.87
Free Cash Flow 4.51
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.64
Cash from Operations 8.95
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 4.01
Free Cash Flow 9.74
Particulars MAR 2020 (Values in Cr)
Net Income -10.54
Cash from Operations 0.76
Cash from Investing -1.90
Cash from Financing 0.43
Net change in Cash -1.47
Free Cash Flow 2.75
Particulars MAR 2024 (Values in Cr)
Net Income -1.22
Cash from Operations 4.50
Cash from Investing -4.69
Cash from Financing -3.65
Net change in Cash -5.61
Free Cash Flow 9.72
Particulars MAR 2023 (Values in Cr)
Net Income -3.61
Cash from Operations -3.53
Cash from Investing -7.26
Cash from Financing -10.02
Net change in Cash -23.59
Free Cash Flow 2.72
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.17
Cash from Operations 8.37
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 3.80
Free Cash Flow 9.17
Particulars MAR 2020 (Values in Cr)
Net Income -9.77
Cash from Operations -0.88
Cash from Investing -1.01
Cash from Financing 0.43
Net change in Cash -1.77
Free Cash Flow 0.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 76.41 13.35 100103.60 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 75.38 183.85 4.73 141.28 51.01 / 98.70
SHREE PACETRONIX LTD. 70.00 14.58 1.87 25.20 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.68 0.00 2.57 27.88 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High

Jeevan Scientific Technology L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
41.78 -2.49 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 42.40
  • 26 Days 42.40
  • 10 Days 42.40
  • 50 Days 43.30
  • 12 Days 42.40
  • 100 Days 45.40
  • 20 Days 42.40
  • 200 Days 48.30
43.03 PIVOT

First Support

42.07

First Resistance

43.81

Second Support

41.29

Second Resistance

44.77

Third Support

40.33

Third Resistance

45.55

RSI

46.40

ADX

20.05

MACD

-0.06

Williams % R

-74.54

Commodity Channel Index (CCI)

38.93

Date

2025-04-30

Week

2320.00

Same Day

1319.00

Month

3202.00

1 Year

0.57

3 Year

0.73

Over 1 Month

2.98%

down

Over 1 Year

-20.41%

down

Over 3 Months

-7.36%

down

Over 3 Years

-26.41%

down

Over 6 Months

-21.68%

down

Over 5 Years

14.96%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Jeevan Scientific Technology L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
61.95%
Promoter Holdings
38.04%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Krishna Kishore Kuchipudi 1935113.0 (12.22%) Shareholding of Promoter and Promoter Group
K Vanaja 1573800.0 (9.94%) Shareholding of Promoter and Promoter Group
Jeevan Krishna Kuchipudi 917772.0 (5.8%) Shareholding of Promoter and Promoter Group
Durisala Desaiah 830000.0 (5.24%) Public Shareholding
Gopi Krishna Kilaru 720000.0 (4.55%) Shareholding of Promoter and Promoter Group
Dheeraj Kumar Lohia 531002.0 (3.35%) Public Shareholding
Nandela Gopalakrishna Reddy 500000.0 (3.16%) Public Shareholding
Radhika Rampa 500000.0 (3.16%) Public Shareholding
Ravi Thammareddy 393200.0 (2.48%) Shareholding of Promoter and Promoter Group
Vidyullatha Kodali 300000.0 (1.89%) Public Shareholding
Ramakrishna Prasad Kakarala 269400.0 (1.7%) Public Shareholding
Nageswara Rao Yarllagadda 230000.0 (1.45%) Public Shareholding
Akhila Kakarala 200000.0 (1.26%) Public Shareholding
K Krishna Kishore 200000.0 (1.26%) Shareholding of Promoter and Promoter Group
Devi Charan Gamini 171163.0 (1.08%) Public Shareholding
Sridevi Thammareddy 121000.0 (0.76%) Shareholding of Promoter and Promoter Group
Jeevan Mitra Chit Fund Private Limited 85200.0 (0.54%) Shareholding of Promoter and Promoter Group
Snigdha Mothukuri 78500.0 (0.5%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Jeevan Scientific Technology L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2022 1.2 Final 23 Sep 2022 Equity shares
07 Sep 2021 0.5 Final 08 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Jeevan Scientific Technology L Share Price

Jeevan Scientific Technology Ltd (Erstwhile Jeevan Softech Limited) was incorporated on 2nd February, 1999 to carry on the business Clinical research, Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable, cost effective and technology-driven clinical research solutions to various clients across the globe.

The Company started with an overall focus on Products Development, International and Domestic markets and Training segment.

During the year 2000-01,the company had developed and released products for Edible Oil Industry,Engineering Industry,Hospital Management.

The company is the member of STPI under 100% Export oriented unit Registration scheme and also achieved Software Exports during 2000-01,to USA based organisation C.S.Consultants Inc.

The company has entered into an agreement with the University of Madras as a strudy centre for Hyderabad to provide MCA,M.Sc,MBA through distance education mode by the Jeevan School of Computer Sciences,a division of Jeevan Softech Limited.

The company had issued 15,20,000 Equity Shares of Rs.10/- each at par to the public during 2000-01 and consequently the Share Capital of the company has risen to Rs.6.04 crores.

In 2011, the Company started Medical Writing Services. It opened Jeevan Scientific New Corporate and Bioanalytical Lab facility in December, 2014. The Clinical Pharmacology Unit with 132 bed capacity opened in Balanagar, Hyderabad in October, 2016. Thereafter, it completed BA/BE studies on 08 June, 2017. In FY 2018-19, the Company acquired nearly 10 LC-MS/MS systems which got launched to accommodate possible work. Thereafter, it started offering clinical research services like Bioavailability/Bioequivalence studies and Phase I to Phase IV services to pharmaceutical and biotechnology industries. In 2021-22, Enhops Solutions Private Limited (ESPL) and Enhops Inc (El), have ceased to be Wholly owned material subsidiaries of the Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Jeevan Scientific Technology Ltd?

Answer Field

The share price of Jeevan Scientific Technology Ltd for NSE is ₹ 0.00 and for BSE is ₹ 41.78.

What is the Market Cap of Jeevan Scientific Technology Ltd?

Answer Field

The market cap of Jeevan Scientific Technology Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 66.20 Cr. as of now.

What is the 52 Week High and Low of Jeevan Scientific Technology Ltd?

Answer Field

The 52 Week High and Low of Jeevan Scientific Technology Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 67.80 and ₹ 37.99.

How to Buy Jeevan Scientific Technology Ltd share?

Answer Field

You can trade in Jeevan Scientific Technology Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Jeevan Scientific Technology Ltd?

Answer Field

The 1 year returns on the stock has been -20.41%.

What is the Current Share Price of Jeevan Scientific Technology Ltd?

Answer Field

Jeevan Scientific Technology Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 41.78 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Jeevan Scientific Technology Ltd Share?

Answer Field

The market cap of Jeevan Scientific Technology Ltd for NSE ₹ 0.0 & for BSE ₹ 66.20 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Jeevan Scientific Technology Ltd share is 49.74.

What is the PB ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Jeevan Scientific Technology Ltd share is 32.36.

How to Buy Jeevan Scientific Technology Ltd Share?

Answer Field

You can trade in Jeevan Scientific Technology Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jeevan Scientific Technology Ltd Share on Bajaj Broking App?

Answer Field

To buy Jeevan Scientific Technology Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jeevan Scientific Technology Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|